Stem cell substance for treating bowel disease
Part of Digestive system clinical trials.
This study looks at how a special substance (called 'secretome') from human stem cells affects inflammation and scarring in inflammatory bowel disease. It is a lab study using tissue samples from people with Crohn's disease or ulcerative colitis to help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- Your disease must be in one of these groups: remission, active and untreated, refractory (not responding to at least 2 treatments), or fibrostenotic Crohn's disease (scarring and narrowing of the intestine).
- You must have intestinal tissue samples (biopsies) available for research.
- You must sign a form agreeing to let researchers use your samples for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of stem cell called HB-adMSCs can help treat Crohn's disease. It is for adults with mild to moderate Crohn's who have certain signs of inflammation in their blood and recent imaging of their condition.
This study tests injections of stem cells placed directly into Crohn’s affected tissue. It may help people whose Crohn’s disease lesions have not responded to standard medicines and biologic therapies.
This trial tests whether injecting donated stem cells into complex anal fistulas can help heal them in people with Crohn's disease. You may qualify if you have a fistula that hasn't improved with standard treatments.
This study tests whether a new treatment made from stem cell particles (called exosomes) can help calm moderate-to-severe ulcerative colitis when standard medicines haven't worked well enough. The treatment is given directly into the vein or under the skin, and the goal is to reduce symptoms and inflammation in the colon.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This study tests a new treatment made from stem cells (from umbilical cord fluid) that may help reduce liver scarring and improve liver function in people with cirrhosis. It is an early-stage trial to see if the treatment is safe and feasible.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.